Upgrades For AnaptysBio Inc (NASDAQ:ANAB), Guggenheim upgraded the previous rating of Neutral to Buy. AnaptysBio earned $1.15 in the second quarter, compared to $0.02 in the year-ago quarter. The sto

Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today

08:27pm, Friday, 28'th Oct 2022 The Motley Fool
The biotech is ceasing its internally funded efforts to develop a heterologous coronavirus booster.
The biotech is ceasing its internally funded efforts to develop a heterologous coronavirus booster.
Immunocore Holdings PLC Sponsored ADR (IMCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving hi
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case

Why Inovio Pharmaceuticals' Shares Jumped 17.31% on Monday

09:59pm, Monday, 17'th Oct 2022 The Motley Fool
The stock jumped Monday despite no news from the company.
The stock jumped Monday despite no news from the company.
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Cameco Corporation (NYSE: CCJ) shares dropped 11.7% to $22.75 in pre-
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) H.C. Wainwright 24th Annual Global Investment Conference September 12, 2022 7:00 AM ET Company Participants Jacqueline Shea - President and CEO Conference Ca

1 Green Flag and 1 Red Flag For Inovio Pharmaceuticals

02:53pm, Sunday, 11'th Sep 2022 The Motley Fool
Can the company still count on its coronavirus-related efforts?
Can the company still count on its coronavirus-related efforts?

Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate

02:12pm, Wednesday, 07'th Sep 2022 Zacks Investment Research
Emergent BioSolutions (EBS) initiates an early-stage study evaluating its Lassa virus vaccine candidate, EBS-LASV, for the prevention of Lassa fever.
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. BioAtla, Inc. (NASDAQ: BCAB) jumped 83.1% to close at $6.61 on Wednesd

Why Inovio Pharmaceuticals Is Gaining Today

07:32pm, Wednesday, 10'th Aug 2022 The Motley Fool
Its newly announced cost-saving measures are getting a warm reception.

Why Inovio Pharmaceuticals Is Gaining Today

03:32pm, Wednesday, 10'th Aug 2022
Its newly announced cost-saving measures are getting a warm reception.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE